India Audits 1,100+ Cough Syrup Makers Amid Crackdown
India has inspected nearly 90% of its cough syrup manufacturers and taken 950+ regulatory actions — here’s what buyers sourcing
Read More
Manufacturing
Daily intelligence on pharma manufacturing — CDMO and contract manufacturing moves, GMP compliance and FDA warning letters, facility investment, and production capacity across the global pharmaceutical supply chain.
FDA’s GDUFA IV Adds Onshoring Incentives for Generics
FDA’s new GDUFA IV proposal keeps the 10-month review target and adds real incentives for domestic generic drug manufacturing. The
Read More
CDMO Capacity Crunch Persists Despite New Investment
Nearly half of biopharma companies still can’t find CDMO capacity — even as sponsors turn their own plants into contract
Read More
Top 10 India Pharma Manufacturers CDMOs 2026
With 350+ USFDA-registered facilities and 30-40% lower costs, these are the Indian CDMOs capturing China+1 diversification demand in 2026. India
Read More
Top 10 UK & EU Pharma Manufacturers CDMOs 2026
With 74% of Europe’s APIs still sourced from Asia, these are the UK and EU CDMOs positioned to capture reshoring
Read More
Top 10 US Pharma Manufacturers CDMOs Ranked 2026
The US CDMO market is racing past $39 billion as sponsors reshore from China — here’s who actually has the
Read More